In Treatment of Bacterial infections Mypod DX 200mg/500mg Tablet SR is used to treat certain bacterial infections like sinus infections (sinusitis), chest infections such as bronchitis and pneumonia, and infections of the ears, skin, throat, stomach, and urinary tract. It works by killing the bacteria causing infections in the body. This further reduces the discomforts associated with various infections and helps in early recovery. Make sure to complete the full course of treatment. This will ensure that the infection is completely cured and prevent it from returning.
It is not known whether it is safe to consume alcohol with Mypod DX 200mg/500mg Tablet SR. Please consult your doctor.
Mypod DX 200mg/500mg Tablet SR is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Mypod DX 200mg/500mg Tablet SR is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Mypod DX 200mg/500mg Tablet SR may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Mypod DX 200mg/500mg Tablet SR should be used with caution in patients with severe kidney disease. Dose adjustment of Mypod DX 200mg/500mg Tablet SR may be needed. Please consult your doctor. Dose adjustment is not recommended in patients with mild and moderate kidney disease.
There is limited information available on the use of Mypod DX 200mg/500mg Tablet SR in patients with liver disease. Please consult your doctor.
If you miss a dose of Mypod DX 200mg/500mg Tablet SR, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Biorika Healthcare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Alkem Laboratories Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Pax Healthcare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Smayan Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Acinom Healthcare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Alobiote Healthcare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Macleods Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Mankind Pharma Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Iva Healthcare Pvt. Ltd. || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Edward Young Labs || ₹14.5/tablet (25% cheaper)